What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Study reveals that it is crucial that critical care nurses are aware of the guidelines for the prevention of ventilator-associated pneumonia A study published recently in ‘Medicina Intensiva’, coordinated by the CIBER of Respiratory Diseases and Vall d'Hebron University Hospital, signifies the great importance of knowledge of guidelines for the prevention of ventilator-associated pneumonia (VAP) by intensive care nurses. Pneumonia is rec News VHIR leads project grants for health research from Instituto de Salud Carlos III Vall d'Hebron Institute of Research (VHIR) is the center associated with Spanish hospitals which received more grants from the Instituto de Salud Carlos III (ISCIII ) for the fourth quarter of 2010. The 31 projects, totaling the amount financed of 3,919,909.50 euros, from 23 different research group News European Rare Disease Day Dr. Antoni Andreu, Head of the Neuromuscular and Mitochondrial Diseases Research Group at Vall d’Hebron Research Institute (VHIR), is interviewed by OrphaNews on the occasion of European rare diseases day. Dr. Andreu, CIBERER member, explains his experience with McArdle disease database, a project t News VHIR's study proves the benefits of a not approved drug for the treatment of ADHD in adults A review study led by Vall d'Hebron Institute of Research (VHIR) has confirmed the efficacy of methylphenidate for adults with Attention Deficit Disorder with Hyperactivity (ADHD). So far, the European Union authorizes treatment with methylphenidate (a stimulant) for children with Attention Deficit News Vall d'Hebron organizes 'Ventilung', the first basic course in mechanical ventilation Ventilung, a course on basics of artificial ventilation and its main clinical applications, will be held at Vall d’Hebron University Hospital (HUVH) from 24 to 26 February, is co-organized by three groups of CIBER of Respiratory Diseases (CIBERES)-belonging to the Instituto de Salud Carlos III- led News Dr. Boada explains the keys of Alzheimer on TVE show 'Saber Vivir' Dr. Mercè Boada, Alzheimer's group leader at Vall d'Hebron Institute of Research (VHIR) appeared on Friday 18 February as the main guest of TVE morning show 'Saber Vivir', where she explained the keys to Alzheimer's and how it affects the daily lives of those affected, and the problems involved and News ISCIII's Master students visit VHIR Students of Master in Management R & D & I in Health Sciences from Institute of Health Carlos III (ISCIII) visited on February 18 the facilities of Vall d'Hebron Institute of Research (VHIR) to know the inner workings of each of its key areas. During the meeting, the leaders of the various units, in News VHIR works with Korean institutions in biomedical research Dr. Antoni Andreu, head of the group of neuromuscular and mitochondrial pathology, and Dr. Joan Montaner, head of neurovascular disease group of Vall d'Hebron Institute of Research (VHIR) participate from 17 to 19 February in Daegu (South Korea) in the second meeting of International Medical Researc News Dr. Reventós explains prostate cancer on Teletaxi with Justo Molinero The head of the Biomedical Research and Translational and Pediatric Oncology Unit at Vall d'Hebron, Institut de Recerca (VHIR), Dr. Jaume Reventós, explains his team's research on prostate cancer and other topics related to innovation and day-to-day research in-depth interview in the program 'Qui és News Inveready takes a stake in Transbiomed, the first spin-off of VHIR Inveready Seed Capital, Venture Capital led and participated by Inveready Group, has announced its investment in the company Transbiomed in its first round of funding. Inveready has taken a minority but significant in this firm, the first spin-off of Vall d'Hebron Research Institute (VHIR) in Barcel News Dr. Galiñanes participates in the special about heart attacks in '36, 5' show at BTV The head of Cardiac Surgery at the Heart Area of the University Hospital Vall d'Hebron, and head of the reparative therapy of heart group at Vall d'Hebron Institut de Recerca (VHIR), Dr. Manuel Galiñanes, explains that exercise is the key to living in health, even for people who suffer heart disease News 2nd SMD Integrated Diagnostic Workshop Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on February 9 the second Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases. The workshop second edition, led by Teresa Vallespí, hematologist of Vall d'Hebron Resea News TVE ‘Informe Semanal' highlights Vall d'Hebron as one of the pioneers in the new lines of cancer research TVE show 'Informe Semanal' covered on February 5, in the context of the ‘Day against cancer’, the new pioneering research lines that are carrying out some Spanish hospitals, including especially Vall d'Hebron. Dr. Josep Baselga, VHIO director, and Dr. Anna Vivancos, among others researchers, give th News EU communication action on VHIR’s Meta Hit project "http://www.youtube.com/user/ComedScienceFilms#p/u/8/pGpBj5T0-DY" COMED is a ‘Communication and Support Action’ within the Seventh Framework of the European Commission to communicate the results and activities of cutting-edge EU-funded health-research projects to the general public. One of them is t News A study investigates if some fat of the diet provides benefits in the treatment of Multiple Sclerosis An international study led by Dr. Xavier Montalban, responsible of the Neuroimmunology Research Group at Vall d'Hebron Research Institute (VHIR) and director of CEM-Cat, examines whether the administration of certain lipids has benefits in the treatment of Multiple Sclerosis (MS). Specifically study News Vall d'Hebron's research, finalist in the 'Vanguardia de la Ciencia' awards "http://www.vhir.org/salapremsa/noticies/noticies_detall.asp?Idioma=en&mv1=5&mv2=3&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2010&num=269" A global study of the Vall d'Hebron Universitary Hospital, led by the group of Gene Expression and Cancer at Vall d'Hebron Institute of Oncology, that identified cells w News Early treatment with antivirals reduces 13% mortality for influenza A Antiviral use in patients with influenza A can reduce up to 13% mortality if used during the first 48 hours since the first symptoms, according to results of a study coordinated by the head of the ICU department at Vall d'Hebron Hospital and reponsible of the Intensive Medicine group at Vall d'Hebro News Vall d'Hebron patents and sells a test that improves breast cancer treatment Vall d'Hebron researchers led by Dr. Joaquin Arribas have created a test to improve the treatment of breast cancer, have patented it and sold the license to the multinational pharmaceutical company GlaxoSmithKline to make it available to patients anywhere in the world. The discovery of this group of News Dr. Antolin explains on TVE the progress in the research of the intestinal flora Dr. Maria Antolin, from the research group in digestive physiology and pathophysiology of Vall d'Hebron Research Institute (VHIR), explains in the tv show 'La Mañana de la 1' of TVE, the study that points the possibility to validate treatments that can make changes in the composition of the intestin News Dr. Rello analyzes the first 100 cases of influenza A this season The head of the ICU department at Vall d'Hebron Hospital and reponsible of the Intensive Medicine group at Vall d'Hebron Research Institute (VHIR)), Dr. Jordi Rello, is examining the first hundred revenues of influenza A H1N1 in Spanish ICUs in a coordinated effort by the Spanish Society of Intensiv Pagination First page « Previous page ‹ … Page 146 Page 147 Current page 148 Page 149 Page 150 … Next page › Last page »
